We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ALT

Price
7.03
Stock movement up
+0.25 (3.69%)
Company name
Altimmune Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
620.45M
Ent value
603.46M
Price/Sales
11931.71
Price/Book
4.65
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-34.69%
1 year return
18.75%
3 year return
-8.31%
5 year return
-1.75%
10 year return
-34.96%
Last updated: 2025-08-27

DIVIDENDS

ALT does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales11931.71
Price to Book4.65
EV to Sales11605.03

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count88.26M
EPS (TTM)-1.46
FCF per share (TTM)-1.10

Income statement

Loading...
Income statement data
Revenue (TTM)52.00K
Gross profit (TTM)-2.01M
Operating income (TTM)-99.51M
Net income (TTM)-103.52M
EPS (TTM)-1.46
EPS (1y forward)-1.40

Margins

Loading...
Margins data
Gross margin (TTM)-3857.69%
Operating margin (TTM)-191365.38%
Profit margin (TTM)-199076.92%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash31.47M
Net receivables428.00K
Total current assets145.76M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets147.86M
Accounts payable1.13M
Short/Current long term debt1.77M
Total current liabilities8.64M
Total liabilities14.49M
Shareholder's equity133.38M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-78.12M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-78.12M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-77.61%
Return on Assets-70.01%
Return on Invested Capital-77.43%
Cash Return on Invested Capital-58.43%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open6.85
Daily high7.52
Daily low6.63
Daily Volume7.87M
All-time high2724.00
1y analyst estimate17.20
Beta-0.01
EPS (TTM)-1.46
Dividend per share-
Ex-div date6 Feb 2017
Next earnings date11 Nov 2025

Downside potential

Loading...
Downside potential data
ALTS&P500
Current price drop from All-time high-99.74%-3.04%
Highest price drop-99.94%-56.47%
Date of highest drop19 Nov 20199 Mar 2009
Avg drop from high-80.07%-11.04%
Avg time to new high234 days12 days
Max time to new high4812 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ALT (Altimmune Inc) company logo
Marketcap
620.45M
Marketcap category
Small-cap
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Employees
59
Investor relations
SEC filings
CEO
Vipin K. Garg
Country
USA
City
Gaithersburg
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...